1. Home
  2. RBB vs MYGN Comparison

RBB vs MYGN Comparison

Compare RBB & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RBB Bancorp

RBB

RBB Bancorp

HOLD

Current Price

$26.56

Market Cap

451.0M

Sector

Finance

ML Signal

HOLD

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

HOLD

Current Price

$5.45

Market Cap

444.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RBB
MYGN
Founded
2008
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
451.0M
444.2M
IPO Year
2017
1996

Fundamental Metrics

Financial Performance
Metric
RBB
MYGN
Price
$26.56
$5.45
Analyst Decision
Hold
Buy
Analyst Count
2
7
Target Price
$22.00
$7.64
AVG Volume (30 Days)
203.3K
1.0M
Earning Date
04-20-2026
05-05-2026
Dividend Yield
2.68%
N/A
EPS Growth
24.49
N/A
EPS
0.66
N/A
Revenue
$5,167,000.00
$771,400,000.00
Revenue This Year
$20.50
$6.86
Revenue Next Year
$6.90
$5.45
P/E Ratio
$39.82
N/A
Revenue Growth
N/A
2.33
52 Week Low
$16.74
$3.53
52 Week High
$28.24
$8.59

Technical Indicators

Market Signals
Indicator
RBB
MYGN
Relative Strength Index (RSI) 50.36 48.29
Support Level $20.11 $4.24
Resistance Level $28.22 $5.71
Average True Range (ATR) 0.80 0.28
MACD -0.20 -0.11
Stochastic Oscillator 34.06 1.09

Price Performance

Historical Comparison
RBB
MYGN

About RBB RBB Bancorp

RBB Bancorp operates as a bank holding company. It provides various banking products and services such as checking, savings, money market accounts, and certificates of deposits. Its Specific services include remote deposit, E-banking, mobile banking, commercial and investor real estate loans, business loans and lines of credit, Small Business Administration (SBA) 7A and 504 loans, mortgage loans, trade finance, and a full range of depository accounts. It generates its revenue from interest received on loans and leases and, to a lesser extent, from interest received on investment securities and derives income from noninterest sources, such as fees received in connection with various lending and deposit services, loan servicing, gain on sales of loans, and wealth management services.

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

Share on Social Networks: